YOLFTbeta
EUROPEAN MEDICAL SOLUTIONS

EUROPEAN MEDICAL SOLUTIONS

ALEMS · BR · Healthcare / Biotechnology

3.44EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close3.44
Open3.44
Day Range3.44 – 3.44
52-Week Range3.40 – 5.50
Volume1
Market Cap16.50M
P/E (TTM)8.48
Forward P/E0.00
EPS0.46
Dividend Yield0.00%
Beta0.15
50-Day Avg3.91
200-Day Avg4.71

About

European Medical Solutions engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium and internationally. The company offers ADAM, a software solution for imaging; R/F solutions, including PLATINUM NEO, a solution that revolutionizes the R/F workflow through an interface and AI-powered image processing; OPTIMA, a performance remote-controlled table designed to provide, imaging solution for radiography and fluoroscopy examinations; and Optima, a imaging solution for radiography and fluoroscopy examinations. It also provides bone densitometry and body composition analysis equipment; chest and bone rooms, such as floor and ceiling tube stands; ambulatory radiography equipment; retrofit kits; C-ARM mobile operating room solutions; and mammography solutions. The company was formerly known as DMS Imaging SA and changed its name to European Medical Solutions in June 2024. European Medical Solutions was founded in 1997 and is headquartered in Brussels, Belgium. European Medical Solutions is a subsidiary of Diagnostic Medical Systems S.A.

Company Details

Leadership

  • Mr. Samuel SancerniMD, CEO & Chairman
  • Ms. Valerie PugnaloniChief Financial Officer
  • Mr. Jerome DelanoeChief Operating Officer
  • Ms. Nathalie Caire RichardHuman Resource Director

Financials

Income Statement

Currency: EUR2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue7.00K5.00K4.00K1.68M604.00K570.75K1.06M358.94K38.02M37.06M40.56M45.13M49.92M
Growth (%)--28.57%-20.00%+41978.92%-64.12%-5.50%+86.57%-66.29%+10491.90%-2.53%+9.47%+11.26%+10.62%
Cost of Revenue3.00K-3.00K-----24.22M23.28M27.05M30.18M33.48M
Gross Profit10.00K5.00K1.00K1.68M604.00K570.75K1.06M358.94K13.80M13.78M13.51M14.96M16.45M
Gross Margin142.86%100.00%25.00%100.00%100.00%100.00%100.00%100.00%36.31%37.18%33.31%33.14%32.94%
Operating Expense2.31M4.32M7.64M13.96M12.58M13.34M17.02M1.26M13.77M19.07M13.65M13.70M13.77M
Operating Income-2.30M-4.32M-7.64M-12.28M-11.97M-12.77M-15.95M-897.00K29.00K-5.29M-135.00K1.25M2.68M
Operating Margin-32828.57%-86360.00%-191000.00%-729.46%-1982.62%-2236.88%-1497.97%-249.90%0.08%-14.28%-0.33%2.78%5.37%
EBITDA-2.27M-4.30M-7.53M-12.14M-11.77M-12.51M--514.66K2.05M-1.25M2.06M3.77M4.83M
EBITDA Margin-32371.43%-85940.00%-188325.00%-721.09%-1948.68%-2192.55%--143.38%5.39%-3.38%5.08%8.35%9.67%
Net Income-2.32M-4.43M-7.71M-12.34M-11.99M-14.32M-15.66M-1.36M-241.00K-5.58M-709.00K546.00K1.84M
Net Income Margin-33128.57%-88580.00%-192875.00%-733.09%-1984.44%-2509.15%-1470.27%-379.45%-0.63%-15.05%-1.75%1.21%3.69%
R&D1.67M3.54M6.69M12.12M10.90M10.86M13.91M53.00K040.00K2.00K0-
R&D as % of Total Revenue23857.14%70820.00%167275.00%720.25%1805.13%1902.06%1306.02%14.77%0.00%0.11%0.00%0.00%-
Interest Expense31.00K112.00K102.00K----503.00K200.00K237.00K432.00K686.00K738.00K
Interest Expense % of Total Revenue442.86%2240.00%2550.00%----140.13%0.53%0.64%1.06%1.52%1.48%

Balance Sheet

Currency: EUR2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.37M8.78M5.47M15.55M4.29M11.55M6.81M5.14M36.30M39.89M43.76M48.47M51.79M
Total Liabilities1.33M1.28M6.33M2.42M3.09M5.09M10.98M10.77M25.41M29.25M33.87M38.13M39.73M
Total Equity42.00K7.43M-858.00K13.13M1.20M6.47M-4.18M-5.63M10.80M10.64M9.89M10.34M12.06M
Cash1.25M8.44M4.62M13.39M2.13M8.46M3.65M2.85M2.43M4.23M4.20M4.58M4.89M
Total Debt885.00K-4.23M431.00K466.00K2.11M5.16M5.66M13.50M14.66M17.92M20.87M19.08M
Net Debt-360.00K-8.44M-389.00K-12.96M-1.66M-6.35M1.51M2.80M10.43M10.43M13.72M16.30M14.19M

Cash Flow

Currency: EUR2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.11M-3.38M-7.92M-13.70M-12.84M-13.02M-12.97M-1.38M348.00K2.09M-2.27M2.56M5.38M
Investing Cash Flow-26.00K-192.00K-371.00K-389.00K-161.00K-371.00K-95.00K638.00K-1.34M-992.00K-1.51M-2.89M-2.88M
Financing Cash Flow865.00K10.77M4.47M22.85M1.73M19.72M8.26M-59.00K2.00M706.00K3.74M718.00K-2.19M
Capital Expenditure26.00K182.00K372.00K383.00K161.00K371.00K97.00K01.92M2.21M2.57M3.57M2.88M
Free Cash Flow-2.14M-3.56M-8.29M-14.08M-13.00M-13.39M-13.07M-1.38M-1.57M-117.00K-4.84M-1.02M2.49M
Dividends Paid--------521.00K----
FCF to OCF101.23%105.39%104.70%102.80%101.25%102.85%100.75%100.00%-452.01%-5.59%212.97%-39.77%46.40%
Dividend Paid to FCF---------33.12%----

Earnings

Report DateSep 14, 2017Apr 18, 2018Sep 19, 2018Apr 2, 2019Feb 4, 2020May 8, 2020Sep 30, 2020May 3, 2021Sep 30, 2021Apr 30, 2022Sep 30, 2022Apr 28, 2023Apr 14, 2025Sep 29, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual-0.53-0.40-0.34-0.91-0.40-0.37-0.060.00-0.010.180.000.000.040.23
Surprise--------------
Timing--------------

Key Statistics & Ratios

Market Cap16.50M
Enterprise Value34.40M
Trailing P/E8.48
Forward P/E0.00
Price / Sales0.32
Price / Book1.35
EPS0.46
Book Value3.11
Revenue (TTM)51.36M
Gross Profit (TTM)18.93M
EBITDA2.52M
Profit Margin3.77%
Operating Margin6.40%
Return on Equity16.91%
Return on Assets3.48%
Shares Outstanding4.23M
Shares Float444.85K
Beta0.15
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Dec 27, 20241:352